JPMorgan Funds - Thematics - Genetic Therapies D (acc) - USD/  LU2228920075  /

Fonds
NAV2024-06-10 Chg.-0.5100 Type of yield Investment Focus Investment company
66.1000USD -0.77% reinvestment Equity Worldwide JPMorgan AM (EU)